Fig. 5

Evaluation of ICD-related lncRNAs risk model in 371 LUSC patients; (A) Cross-validation for adjusting parameter selections in the LASSO model; (B) LASSO coefficient profiles; (C-D) Univariate (C) and multivariate (D) Cox regression analysis to assess the effect of risk score on the prognosis of LUSC patients; (E) Risk scores (up) and survival outcome (down) of each sample; (F) Survival analysis of LUSC patients in high risk and low risk sets; (G) ROC curve for predicting the prognoses of LUSC patients basing on risk scores; (H) Expression of ICD-related lncRNAs in high risk and low risk sets